The future of toxicology and chemical safety lies at the intersection of innovative technologies, collaboration, and a willingness to embrace new approaches. Dr. Tomasz Sobanski (ECHA’s Alternative Methods Team) and Prof. Mark Viant (Michabo Health Science Ltd) came together in a PrecisionTox Webinar to discuss with our stakeholders how omics technologies can redefine risk assessment and chemical safety.
Read online
Read their summary in this Editorial
